Nouri Neamati

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Topics

Protein Protein

Reactive Oxygen Species

Endoplasmic Reticulum

Top Venues

Journal of medicinal chemistry

ACS pharmacology & translational science

ACS infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Tiangong Lu, Fangfang Chen, Jian Yao, Zixuan Bu, Armita Kyani, Benji Liang, Shaoting Chen, Yuxiang Zheng, Hong Liang, Nouri Neamati, Yanghan Liu
Design of FK866-Based Degraders for Blocking the Nonenzymatic Functions of Nicotinamide Phosphoribosyltransferase. Journal of medicinal chemistry (2024)
Tiangong Lu, Fangfang Chen, Jian Yao, Zixuan Bu, Armita Kyani, Benji Liang, Shaoting Chen, Yuxiang Zheng, Hong Liang, Nouri Neamati, Yanghan Liu
Design of FK866-Based Degraders for Blocking the Nonenzymatic Functions of Nicotinamide Phosphoribosyltransferase. Journal of medicinal chemistry 67 (10) (2024)
Joyeeta Roy, Armita Kyani, Maha Hanafi, Yibin Xu, John Takyi-Williams, Duxin Sun, Essam Eldin A Osman, Nouri Neamati
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer. Journal of medicinal chemistry (2023)
Joyeeta Roy, Armita Kyani, Maha Hanafi, Yibin Xu, John Takyi-Williams, Duxin Sun, Essam Eldin A Osman, Nouri Neamati
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer. Journal of medicinal chemistry 66 (3) (2023)
Yibin Xu, Ding Xue, Armita Kyani, Armand Bankhead, Joyeeta Roy, Mats Ljungman, Nouri Neamati
First-in-Class NADH/Ubiquinone Oxidoreductase Core Subunit S7 (NDUFS7) Antagonist for the Treatment of Pancreatic Cancer. ACS pharmacology & translational science 6 (8) (2023)
Joyeeta Roy, Armita Kyani, Maha Hanafi, Yibin Xu, John Takyi-Williams, Duxin Sun, Essam Eldin A Osman, Nouri Neamati
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer. Journal of medicinal chemistry 66 (3) (2023)
Joyeeta Roy, Armita Kyani, Maha Hanafi, Yibin Xu, John Takyi-Williams, Duxin Sun, Essam Eldin A Osman, Nouri Neamati
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer. Journal of medicinal chemistry 66 (3) (2023)
Yuting Kuang, Na Ye, Armita Kyani, Mats Ljungman, Michelle Paulsen, Haijun Chen, Mingxiang Zhou, Christopher Wild, Haiying Chen, Jia Zhou, Nouri Neamati
Induction of Genes Implicated in Stress Response and Autophagy by a Novel Quinolin-8-yl-nicotinamide QN523 in Pancreatic Cancer. Journal of medicinal chemistry 65 (8) (2022)
Nouri Neamati
Advances Toward COVID-19 Therapies Special Issue. Journal of medicinal chemistry 65 (4) (2022)
Ding Xue, Yibin Xu, Armita Kyani, Joyeeta Roy, Lipeng Dai, Duxin Sun, Nouri Neamati
Multiparameter Optimization of Oxidative Phosphorylation Inhibitors for the Treatment of Pancreatic Cancer. Journal of medicinal chemistry 65 (4) (2022)
Ding Xue, Yibin Xu, Armita Kyani, Joyeeta Roy, Lipeng Dai, Duxin Sun, Nouri Neamati
Discovery and Lead Optimization of Benzene-1,4-disulfonamides as Oxidative Phosphorylation Inhibitors. Journal of medicinal chemistry 65 (1) (2022)
Rima Mouawad, Nouri Neamati
Inhibition of Protein Disulfide Isomerase (PDIA1) Leads to Proteasome-Mediated Degradation of Ubiquitin-like PHD and RING Finger Domain-Containing Protein 1 (UHRF1) and Increased Sensitivity of Glioblastoma Cells to Topoisomerase II Inhibitors. ACS pharmacology & translational science 6 (1) (2022)
Rima Mouawad, Nouri Neamati
Inhibition of Protein Disulfide Isomerase (PDIA1) Leads to Proteasome-Mediated Degradation of Ubiquitin-like PHD and RING Finger Domain-Containing Protein 1 (UHRF1) and Increased Sensitivity of Glioblastoma Cells to Topoisomerase II Inhibitors. ACS pharmacology & translational science 6 (1) (2022)
Dennis C Liotta, James C Barrow, Kelly Chibale, Maria Laura Bolognesi, Stuart J Conway, William Alexander Denny, Ke Ding, Stefan A Laufer, Luhua Lai, Hong Liu, Nouri Neamati, Takayoshi Suzuki, Nicholas A Meanwell, Wendy B Young
Simplifying Submission Requirements for the Journal of Medicinal Chemistry. Journal of medicinal chemistry 64 (12) (2021)
Maha Hanafi, Xinde Chen, Nouri Neamati
Discovery of a Napabucasin PROTAC as an Effective Degrader of the E3 Ligase ZFP91. Journal of medicinal chemistry 64 (3) (2021)
Essam Eldin A Osman, Alnawaz Rehemtulla, Nouri Neamati
Why All the Fury over Furin? Journal of medicinal chemistry (2021)
Wenmin Chen, Shuai Hu, Shuai Mao, Yibin Xu, Hui Guo, Haoxi Li, Michelle T Paulsen, Xinde Chen, Mats Ljungman, Nouri Neamati
Discovery of Mitochondrial Transcription Inhibitors Active in Pancreatic Cancer Cells. ChemMedChem 15 (21) (2020)
Yibin Xu, Ding Xue, Armand Bankhead, Nouri Neamati
Why All the Fuss about Oxidative Phosphorylation (OXPHOS)? Journal of medicinal chemistry 63 (23) (2020)
Essam Eldin A Osman, Peter L Toogood, Nouri Neamati
COVID-19: Living through Another Pandemic. ACS infectious diseases 6 (7) (2020)
Andrea Shergalis, Ding Xue, Fatma Z Gharbia, Hannah Driks, Binita Shrestha, Amina Tanweer, Kirin Cromer, Mats Ljungman, Nouri Neamati
Characterization of Aminobenzylphenols as Protein Disulfide Isomerase Inhibitors in Glioblastoma Cell Lines. Journal of medicinal chemistry 63 (18) (2020)
Hong Liu, Nouri Neamati, Nicholas A Meanwell, Wendy B Young, Gunda I Georg, Shaomeng Wang
Advances toward COVID-19 Therapies Special Issue Call for Papers. Journal of medicinal chemistry 63 (24) (2020)
Suhui Yang, Andrea Shergalis, Dan Lu, Anahita Kyani, Ziwei Liu, Mats Ljungman, Nouri Neamati
Design, Synthesis, and Biological Evaluation of Novel Allosteric Protein Disulfide Isomerase Inhibitors. Journal of medicinal chemistry 62 (7) (2019)
Weiyang Dai, Soma Samanta, Ding Xue, Elyse M Petrunak, Jeanne A Stuckey, Yanyan Han, Duxin Sun, Yong Wu, Nouri Neamati
Structure-Based Design of N-(5-Phenylthiazol-2-yl)acrylamides as Novel and Potent Glutathione S-Transferase Omega 1 Inhibitors. Journal of medicinal chemistry 62 (6) (2019)
Mariateresa Badolato, Francesca Aiello, Nouri Neamati
2,3-Dihydroquinazolin-4(1 H )-one as a privileged scaffold in drug design. RSC advances 8 (37) (2018)
Joseph T Madak, Christine R Cuthbertson, Yoshinari Miyata, Shuzo Tamura, Elyse M Petrunak, Jeanne A Stuckey, Yanyan Han, Miao He, Duxin Sun, Hollis D Showalter, Nouri Neamati
Design, Synthesis, and Biological Evaluation of 4-Quinoline Carboxylic Acids as Inhibitors of Dihydroorotate Dehydrogenase. Journal of medicinal chemistry 61 (12) (2018)
Yuting Kuang, Mario Sechi, Salvatore Nurra, Mats Ljungman, Nouri Neamati
Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma. Journal of medicinal chemistry 61 (4) (2018)